Overview: how is alcohol metabolized by the body?

Samir Zakhari, Samir Zakhari

Abstract

Alcohol is eliminated from the body by various metabolic mechanisms. The primary enzymes involved are aldehyde dehydrogenase (ALDH), alcohol dehydrogenase (ADH), cytochrome P450 (CYP2E1), and catalase. Variations in the genes for these enzymes have been found to influence alcohol consumption, alcohol-related tissue damage, and alcohol dependence. The consequences of alcohol metabolism include oxygen deficits (i.e., hypoxia) in the liver; interaction between alcohol metabolism byproducts and other cell components, resulting in the formation of harmful compounds (i.e., adducts); formation of highly reactive oxygen-containing molecules (i.e., reactive oxygen species [ROS]) that can damage other cell components; changes in the ratio of NADH to NAD+ (i.e., the cell's redox state); tissue damage; fetal damage; impairment of other metabolic processes; cancer; and medication interactions. Several issues related to alcohol metabolism require further research.

Conflict of interest statement

Financial Disclosure

The author declares that he has no competing financial interests.

Figures

Figure 1
Figure 1
Oxidative pathways of alcohol metabolism. The enzymes alcohol dehydrogenase (ADH), cytochrome P450 2E1 (CYP2E1), and catalase all contribute to oxidative metabolism of alcohol. ADH, present in the fluid of the cell (i.e., cytosol), converts alcohol (i.e., ethanol) to acetaldehyde. This reaction involves an intermediate carrier of electrons, +nicotinamide adenine dinucleotide (NAD), which is reduced by two electrons to form NADH. Catalase, located in cell bodies called peroxisomes, requires hydrogen peroxide (H2O2) to oxidize alcohol. CYP2E1, present predominantly in the cell’s microsomes, assumes an important role in metabolizing ethanol to acetaldehyde at elevated ethanol concentrations. Acetaldehyde is metabolized mainly by aldehyde dehydrogenase 2 (ALDH2) in the mitochondria to form acetate and NADH. ROS, reactive oxygen species.
Figure 2
Figure 2
Ethanol is nonoxidatively metabolized by two pathways. A reaction catalyzed by the enzyme fatty acid ethyl ester (FAEE) synthase leads to the formation of molecules known as FAEEs. A reaction with the enzyme phospholipase D (PLD) results in the formation of a phospholipid known as phosphatidyl ethanol.

References

    1. Agarwal DP. Genetic polymorphisms of alcohol metabolizing enzymes. Pathologie-Biologie (Paris) 2001;49:703–709.
    1. Arteel GE, Raleigh JA, Bradford BU, Thurman RG. Acute alcohol produces hypoxia directly in rat liver tissue in vivo: Role of Kupffer cells. American Journal of Physiology. 1996;271:G494–G500.
    1. Bailey SM. A review of the role of reactive oxygen and nitrogen species in alcohol-induced mitochondrial dysfunction. Free Radical Research. 2003;37:585–596.
    1. Bailey SM, Cunningham CC. Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh, isolated rat hepatocytes. Hepatology. 1998;28:1318–1326.
    1. Baraona E. Site and quantitative importance of alcohol first-pass metabolism. Alcoholism: Clinical and Experimental Research. 2000;24:405–406.
    1. Baraona E, Abittan CS, Dohmen K, et al. Gender differences in pharmacokinetics of alcohol. Alcoholism: Clinical and Experimental Research. 2001;25:502–507.
    1. Barry RE, Williams AJ, McGivan JD. The detection of acetaldehyde/liver plasma membrane protein adduct formed in vivo by alcohol feeding. Liver. 1987;7:364–368.
    1. Bennion LJ, Li T-K. Alcohol metabolism in American Indians and whites: Lack of racial differences in metabolic rate and liver alcohol dehydrogenase. New England Journal of Medicine. 1976;294:9–13.
    1. Bleich S, Degner D, Sperling W, et al. Homocysteine as a neurotoxin in chronic alcoholism. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2004;28:453–464.
    1. Bordone L, Guarrente L. Calorie restriction, SIRT1 and metabolism: Understanding longevity. Nature. 2005;6:298–305.
    1. Bosron WF, Ehrig T, Li TK. Genetic factors in alcohol metabolism and alcoholism. Seminars in Liver Disease. 1993;13:126–135.
    1. Bradford BU, Kono H, Isayama F, et al. Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology. 2005;41:336–344.
    1. Burim RV, Canalle R, Martinelli Ade L, Takahashi CS. Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis. 2004;19:291–298.
    1. Chao YC, Liou SR, Chung YY, et al. Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology. 1994;19:360–366.
    1. Cohen-Kerem R, Koren G. Antioxidants and fetal protection against ethanol teratogenicity. I. Review of the experimental data and implications to humans. Neurotoxicology and Teratology. 2003;25:1–9.
    1. Costa LG, Vitalone A, Guizzetti M. Signal transduction mechanisms involved in the antiproliferative effects of ethanol in glial cells. Toxicology Letters. 2004;149(2–3):67–73.
    1. Crabb DW. First-pass metabolism of ethanol: Gastric or hepatic, mountain or molehill. Hepatology. 1997;25:1292–1294.
    1. Crabb DW, Pinairs J, Hasanadka R, et al. Alcohol and retinoids. Alcoholism: Clinical and Experimental Research. 2001;25:207S–217S.
    1. Cunningham CC, Malloy CR, Radda GK. Effect of fasting and acute ethanol administration on the energy state of in vivo liver as measured by 31P-NMR spectroscopy. Biochimica et Biophysica Acta. 1986;885:12–22.
    1. Handler JA, Thurman RG. Redox interactions between catalase and alcohol dehydrogenase pathways of ethanol metabolism in the perfused rat liver. Journal of Biological Chemistry. 1990;265:1510–1515.
    1. Henderson GI, Chen JJ, Schenker S. Ethanol, oxidative stress, reactive aldehydes, and the fetus. Frontiers in Bioscience. 1999;4:D541–D550.
    1. Hines LM, Stampfer MJ, Ma J, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. New England Journal of Medicine. 2001;344:549–555.
    1. Hoek JB, Cahill A, Pastorino JG. Alcohol and mitochondria: A dysfunctional relationship. Gastroenterology. 2002;122:2049–2063.
    1. Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403:795–800.
    1. Ishak KG, Zimmerman HJ, Ray MB. Alcoholic liver disease: Pathologic, pathogenetic and clinical aspects. Alcoholism: Clinical and Experimental Research. 1991;15:45–66.
    1. Israel Y, Hurwitz E, Niemela O, Arnon R. Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proceedings of the National Academy of Sciences USA. 1986;83:7923–7927.
    1. Israel Y, Orrego H, Carmichael FJ. Acetate-mediated effects of ethanol. Alcoholism: Clinical and Experimental Research. 1994;18:144–148.
    1. Kono H, Rusyn I, Yin M, et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. Journal of Clinical Investigation. 2000;106:867–872.
    1. Kopun M, Propping P. The kinetics of ethanol absorption and elimination in twins and supplementary repetitive experiments in singleton subjects. European Journal of Clinical Pharmacology. 1977;11:337–344.
    1. Laposata M. Assessment of ethanol intake current tests and new assays on the horizon. American Journal of Clinical Pathology. 1999;112:443–450.
    1. Lee SL, Chau GY, Yao CT, et al. Functional assessment of human alcohol dehydrogenase family in ethanol metabolism: Significance of first-pass metabolism. Alcoholism: Clinical and Experimental Research. 2006;30:1132–1142.
    1. Lee SL, Wang MF, Lee AI, Yin SJ. The metabolic role of human ADH3 functioning as ethanol dehydrogenase. FEBS Letters. 2003;544:143–147.
    1. Lim RT, Jr, Gentry RT, Ito D, et al. First-pass metabolism of ethanol is predominantly gastric. Alcoholism: Clinical and Experimental Research. 1993;17:1337–1344.
    1. Lin RC, Lumeng L, Shahidi S, et al. Protein-acetaldehyde adducts in serum of alcoholic patients. Alcoholism: Clinical and Experimental Research. 1990;14:438–443.
    1. Lindros KO, Jokelainen K, Nanji AA. Acetaldehyde prevents nuclear factor-kappa B activation and hepatic inflammation in ethanol-fed rats. Laboratory Investigation. 1999;79:799–806.
    1. Luu SU, Wang MF, Lin DL, et al. Ethanol and acetaldehyde metabolism in Chinese with dif ferent aldehyde dehydrogenase-2 genotypes. Proceedings of the National Science Council of the Republic of China B. 1995;19:129–136.
    1. Misra UK, Bradford BU, Handler JA, Thurman RG. Chronic ethanol treatment induces H2O2 production selectively in pericentral regions of the liver lobule. Alcoholism: Clinical and Experimental Research. 1992;16:839–842.
    1. Nagata N, Hiyoshi M, Shiozawa H, et al. Assessment of a difference in ALDH2 heterozygotes and alcoholic liver disease. Alcoholism: Clinical and Experimental Research. 2002;26:11S–14S.
    1. Nagy LE. Molecular aspects of alcohol metabolism: Transcription factors involved in early ethanol-induced liver injury. Annual Review of Nutrition. 2004;24:55–78.
    1. Nakamura Y, Yokoyama H, Higuchi S, et al. Acetaldehyde accumulation suppresses Kupffer cell release of TNF-alpha and modifies acute hepatic inflammation in rats. Journal of Gastroenterology. 2004;39:140–147.
    1. Neumark Y, Friedlander Y, O’Connor S, et al. The influence of alcohol dehydrogenase polymorphisms on alcohol metabolism among Jewish males in Israel (Abstract) Alcoholism: Clinical and Experimental Research. 2001;25:126A.
    1. Niemela O, Parkkila S. Alcoholic macrocytosis: Is there a role for acetaldehyde and adducts? Addiction Biology. 2004;9:3–10.
    1. Poschl G, Seitz HK. Alcohol and cancer. Alcohol and Alcoholism. 2004;39:155–165.
    1. Quintanilla ME, Tampier L, Sapag A, Israel Y. Polymorphisms in the mitochrondrial aldehyde dehydrogenase gene (Aldh2) determine peak blood acetaldehyde levels and voluntary ethanol consumption in rats. Pharmacogenetics and Genomics. 2005;15:1–5.
    1. Seitz HK, Stickel F, Homann N. Pathogenetic mechanisms of upper aerodigestive tract cancer in alcoholics. International Journal of Cancer. 2004;108:483–487.
    1. Shen YC, Fan JH, Edenberg HJ, et al. Polymorphism of ADH and ALDH genes among four ethnic groups in China and effects upon the risk for alcoholism. Alcoholism: Clinical and Experimental Research. 1997;21:1272–1277.
    1. Stickel F, Schuppan D, Hahn EG, Seitz HK. Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut. 2002;51:132–139.
    1. Thomasson HR, Beard JD, Li TK. ADH2 gene polymorphisms are determinants of alcohol pharmacokinetics. Alcoholism: Clinical and Experimental Research. 1995;19:1494–1499.
    1. Tsukamoto H, Xi XP. Incomplete compensation of enhanced hepatic oxygen consumption in rats with alcoholic centrilobular liver necrosis. Hepatology. 1989;9:302–306.
    1. Tuma DJ. Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radical Biology and Medicine. 2002;32:303–308.
    1. Tuma DJ, Casey CA. Dangerous byproducts of alcohol breakdown: Focus on adducts. Alcohol Research & Health. 2003;27:285–290.
    1. Tuma DJ, Thiele GM, Xu D, et al. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology. 1996;23:872–880.
    1. Ueno Y, Adachi J, Imamichi H, et al. Effect of the cytochrome P-450IIE1 genotype on ethanol elimination rate in alcoholics and control subjects. Alcoholism: Clinical and Experimental Research. 1996;20(Suppl):17A–21A.
    1. Wall TL, Garcia-Andrade C, Thomasson HR, et al. Alcohol elimination in Native American Mission Indians: An investigation of interindividual variation. Alcoholism: Clinical and Experimental Research. 1996;20:1159–1164.
    1. Wall TL, Peterson CM, Peterson KP, et al. Alcohol metabolism in Asian-American men with genetic polymorphisms of aldehyde dehydrogenase. Annals of Internal Medicine. 1997;127:376–379.
    1. Werner J, Saghir M, Warshaw AL, et al. Alcoholic pancreatitis in rats: Injury from nonoxidative metabolites of ethanol. American Journal of Physiology Gastrointestinal and Liver Physiology. 2002;283:G65–G73.
    1. Worrall S, De Jersey J, Shanley BC, Wilce PA. Antibodies against acetaldehyde-modified epitopes: presence in alcoholic, non-alcoholic liver disease and control subjects. Alcohol and Alcoholism. 1990;25:509–517.
    1. Worrall S, Thiele GM. Protein modification in ethanol toxicity. Adverse Drug Reactions and Toxicological Reviews. 2001;20:133–159.
    1. Wu D, Cederbaum AI. Alcohol, oxidative stress, and free radical damage. Alcohol Research & Health. 2003;27:277–284.
    1. Yokoyama A, Omori T. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Japanese Journal of Clinical Oncology. 2003;33:111–121.
    1. Zimatkin SM, Deitrich RA. Ethanol metabolism in the brain. Addiction Biology. 1997;2:387–399.
    1. Zintzaras E, Stefanidis I, Santos M, Vidal F. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology. 2006;43(2):352–3361.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren